| Old Articles: <Older 5141-5150 Newer> |
|---|
 |
The Motley Fool
September 25, 2008
Brian Orelli |
Medicis Restates, Investors Panic Medicis says it'll have to restate earnings.   |
The Motley Fool
September 25, 2008
Brian Orelli |
Uh-Oh, Stent Makers Drugs are just as good as stents. |
The Motley Fool
September 25, 2008
Selena Maranjian |
Look What's Booming When times get tough, don't go to lotteries. |
The Motley Fool
September 25, 2008
Brian Orelli |
Teva Heads to Japan It's conquering the world, slowly but surely. But is it still a value play? |
The Motley Fool
September 24, 2008
Brian Orelli |
Hey, You! Stop! The FDA has ordered Baxter and Hospira to stop making their ophthalmic balanced salt solutions within 60 days. |
The Motley Fool
September 24, 2008
Brian Lawler |
One Share Offering Too Many for Vertex? Developmental drugmaker Vertex raises cash again by diluting itself. |
The Motley Fool
September 24, 2008
Brian Orelli |
100% Results From Sequenom The company presents more data on its molecular diagnostic and buys a lab to run the tests in. |
The Motley Fool
September 24, 2008
Brian Lawler |
Bristol-Myers Puts Icahn and ImClone to the Test Despite trying to project different intentions last week, pharma giant Bristol-Myers Squibb raised its bid for ImClone Systems. |
The Motley Fool
September 24, 2008
Brian Lawler |
Sanofi Gets the Golden Ring Sanofi-Aventis raises its bid and acquires Czech generic drugmaker Zentiva. |
The Motley Fool
September 24, 2008
Brian Orelli |
Ariad's Lawsuit Loss and Investors' Gamble Ariad Pharmaceuticals announces that it is on the losing end of its lawsuit. |
| <Older 5141-5150 Newer> Return to current articles. |
